Oscar Health Q4 Revenue Expected to Reach $3.12B, Loss of $0.92 per Share
Oscar Health’s Q3 revenue rose 23.3% to $2.99 billion but missed estimates by 3.3%, even as full-year operating income guidance topped forecasts. Analysts project Q4 revenue of $3.12 billion (30.6% growth) with an adjusted loss of $0.92 per share ahead of potential policy shifts.
1. Q3 Performance
Oscar Health reported Q3 revenue of $2.99 billion up 23.3% year-on-year but missed estimates by 3.3%, while full-year operating income guidance exceeded forecasts.
2. Q4 Projections
Analysts forecast Q4 revenue of $3.12 billion (30.6% growth) and an adjusted loss of $0.92 per share as the company prepares to release results before market open on Tuesday.
3. Peer Comparison
Cigna’s Q4 revenue grew 10.4% beating estimates by 3.8% and Centene’s rose 21.9% topping forecasts by 3%, setting a high bar for Oscar Health’s upcoming report.
4. Outlook and Risks
The 2025 outlook is clouded by potential trade policy changes and corporate tax debates; Oscar shares are down 29.9% over the past month versus a 3.1% sector decline, with an average analyst target of $15.78.